Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics, Inc. financial statements

Cyclerion Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 2.07MEODHD
Net income−USD 3.53MEODHD
Cash and equivalentsUSD 3.24MEODHD

Cyclerion Therapeutics, Inc. financials on 6ix · Cyclerion Therapeutics, Inc. on 6ix